FDA
approval
· 2016-04-11
FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)
Summary
FDA approved a supplemental NDA for Kabiven, a parenteral nutrition emulsion (dextrose, lipids, amino acids and electrolytes). The approval was issued to Fresen…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KABIVEN (DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE)